Related Experiment Video
Updated: Feb 18, 2026
09:51
Human Liver Spheroids from Peripheral Blood for Liver Disease Studies
Published on: January 27, 2023
2.3K
PNPLA3 expression and its impact on the liver: current perspectives
Francesca Virginia Bruschi1, Matteo Tardelli1, Thierry Claudel1
1Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, Austria.
Hepatic Medicine : Evidence and Research
|November 22, 2017
Summary
The PNPLA3 I148M genetic variant increases the risk of fatty liver disease and its progression. This review explores PNPLA3
Area of Science:
- Genetics and Molecular Biology
- Hepatology and Liver Disease
Background:
- The patatin-like phospholipase domain-containing 3 (PNPLA3) gene's I148M variant is strongly linked to hepatic steatosis.
- This variant is associated with more severe liver conditions, including nonalcoholic steatohepatitis, advanced fibrosis, and cirrhosis.
- PNPLA3 I148M also correlates with alcoholic liver disease, hepatitis C-related cirrhosis, and hepatocellular carcinoma.
Purpose of the Study:
- To review current data on PNPLA3 expression in the human liver.
- To analyze the impact of the PNPLA3 I148M genetic variant on human hepatic pathologies.
- To summarize biochemical and metabolic data on PNPLA3 function from animal and in vitro studies.
Main Methods:
- Literature review of recent data on PNPLA3 expression and function.
- Analysis of the association between the PNPLA3 I148M variant and liver diseases.
- Synthesis of findings from animal models and in vitro studies on PNPLA3.
Main Results:
- The PNPLA3 I148M variant is a significant risk factor for various liver diseases.
- PNPLA3's precise role in liver lipid metabolism is still under investigation.
- Evidence suggests divergent regulation of PNPLA3 in different liver cell types, like hepatic stellate cells.
Conclusions:
- The PNPLA3 I148M variant plays a crucial role in the pathogenesis and progression of liver diseases.
- Understanding PNPLA3's function is key to comprehending the development of hepatic pathologies.
- Further research into PNPLA3's biochemical and metabolic roles is warranted.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
212
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
212
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
16
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
16
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
259
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
259
01:58Cell Specific Gene Expression
16.7K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.7K
01:29Pharmacogenomics: Identification of New Drug Targets
20
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
20